GR1002294B - Συνδυασμενο εμβολιο για streptococcus ομαδας β. - Google Patents

Συνδυασμενο εμβολιο για streptococcus ομαδας β.

Info

Publication number
GR1002294B
GR1002294B GR900100692A GR900100692A GR1002294B GR 1002294 B GR1002294 B GR 1002294B GR 900100692 A GR900100692 A GR 900100692A GR 900100692 A GR900100692 A GR 900100692A GR 1002294 B GR1002294 B GR 1002294B
Authority
GR
Greece
Prior art keywords
streptococcus
group
conjugate vaccine
vaccine
protein
Prior art date
Application number
GR900100692A
Other languages
English (en)
Other versions
GR900100692A (el
Inventor
L. Dennis Kasper
M. Frederick Ausubel
L.James Michel
Original Assignee
Brigham And Women's Hospital
The General Hospital Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham And Women's Hospital, The General Hospital Corporation filed Critical Brigham And Women's Hospital
Publication of GR900100692A publication Critical patent/GR900100692A/el
Publication of GR1002294B publication Critical patent/GR1002294B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GR900100692A 1989-09-15 1990-09-12 Συνδυασμενο εμβολιο για streptococcus ομαδας β. GR1002294B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40803689A 1989-09-15 1989-09-15

Publications (2)

Publication Number Publication Date
GR900100692A GR900100692A (el) 1992-01-20
GR1002294B true GR1002294B (el) 1996-05-03

Family

ID=23614587

Family Applications (1)

Application Number Title Priority Date Filing Date
GR900100692A GR1002294B (el) 1989-09-15 1990-09-12 Συνδυασμενο εμβολιο για streptococcus ομαδας β.

Country Status (22)

Country Link
EP (1) EP0491865B1 (el)
JP (2) JPH05500455A (el)
KR (1) KR0180559B1 (el)
AT (1) ATE146081T1 (el)
AU (1) AU641439B2 (el)
CA (2) CA2383393A1 (el)
DE (1) DE69029396T2 (el)
DK (1) DK0491865T3 (el)
ES (1) ES2097154T3 (el)
FI (1) FI105154B (el)
GR (1) GR1002294B (el)
HU (1) HU219327B (el)
IE (1) IE903349A1 (el)
IL (1) IL95578A (el)
NO (1) NO313908B1 (el)
NZ (1) NZ235316A (el)
PL (3) PL167444B1 (el)
PT (1) PT95316A (el)
RU (1) RU2113234C1 (el)
WO (1) WO1991004049A1 (el)
YU (1) YU176490A (el)
ZA (1) ZA907297B (el)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648241A (en) * 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
ES2160601T3 (es) * 1992-09-24 2001-11-16 Brigham & Womens Hospital Vacunas de conjugado de polisacaridos de estreptococos del grupo b tipo ii y tipo v-proteina.
ZA937034B (en) * 1992-09-24 1995-06-23 Brigham & Womens Hospital Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines
AU722078B2 (en) * 1992-11-02 2000-07-20 Brigham And Women's Hospital Conjugate vaccine against group B Streptococcus
IL107458A0 (en) * 1992-11-02 1994-02-27 Gen Hospital Corp Conjugate vaccine against group b streptococcus
DK0656014T3 (da) * 1993-03-19 2003-08-11 Gunnar Lindahl Protein Rib, et celleoverfladeprotein der overfører immunitet mod mange gruppe B Streptococcus stammer, fremgangsmåde til oprensning af proteinet, reagenskit og farmaceutisk komposition
US6015889A (en) * 1993-03-19 2000-01-18 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5439808A (en) * 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US5565204A (en) * 1994-08-24 1996-10-15 American Cyanamid Company Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
US5747287A (en) * 1995-04-28 1998-05-05 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
US6284884B1 (en) 1995-06-07 2001-09-04 North American Vaccine, Inc. Antigenic group B streptococcus type II and type III polysaccharide fragments having a 2,5-anhydro-D-mannose terminal structure and conjugate vaccine thereof
US6444787B1 (en) 1997-12-31 2002-09-03 Research Development Institute, Inc. Method of isolating a peptide which immunologically mimics microbial carbohydrates including group B streptococcal carbohydrates and the use thereof in a vaccine
RU2186389C1 (ru) * 2001-01-09 2002-07-27 Государственное федеральное учреждение науки Уральский научно-исследовательский институт травматологии и ортопедии Способ культивирования h. influenzae из носоглоточной слизи (варианты)
RU2261109C1 (ru) * 2004-01-05 2005-09-27 ГНУ Научно-исследовательский институт пушного звероводства и кролиководства им. В.А. Афанасьева Штамм бактерий streptococcus agalactiae №71 для изготовления вакцин против стрептококкоза пушных зверей
EP1828231A2 (en) * 2004-12-22 2007-09-05 Novartis Vaccines and Diagnostics, Inc. Group b streptococcus
RU2378374C2 (ru) * 2008-03-21 2010-01-10 Учреждение Российской академии медицинских наук Научно-исследовательский институт экспериментальной медицины Северо-Западного отделения РАМН Рекомбинантная днк, обеспечивающая получение рекомбинантного белка pb1, обладающего протективными свойствами в отношении streptococcus pyogenes и streptococcus agalactiae
RU2387715C2 (ru) * 2008-06-18 2010-04-27 Учреждение Российской Академии Медицинских Наук Научно-исследовательский институт экспериментальной медицины Северо-западного отделения РАМН (НИИЭМ СЗО РАМН) РЕКОМБИНАНТНЫЕ ДНК, ОБЕСПЕЧИВАЮЩИЕ ПОЛУЧЕНИЕ ПОЛИПЕПТИДОВ Р6, Р7, Р8, ОБЛАДАЮЩИХ ПРОТЕКТИВНЫМИ СВОЙСТВАМИ В ОТНОШЕНИИ STREPTOCOCCUS AGALACTIAE И СЕЛЕКТИВНО-СВЯЗЫВАЮЩИХ IgA

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4367222A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Immune globulin specific to Group B streptococci
US4367223A (en) * 1980-06-09 1983-01-04 President And Fellows Of Harvard College Vaccine against Group B streptococci
US4356170A (en) * 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
NZ214503A (en) * 1984-12-20 1990-02-26 Merck & Co Inc Covalently-modified neutral bacterial polysaccharides, stable covalent conjugates of such polysaccharides and immunogenic proteins, and methods of preparing such polysaccharides and conjugates
JP2754000B2 (ja) * 1986-04-16 1998-05-20 ザ ブリガム アンド ウィメンズ ホスピタル，インコーポレイテッド 細菌抗原、抗体、ワクチン及びその製造方法
NZ225372A (en) * 1987-07-17 1991-04-26 Xoma Corp Immunotoxin composition comprising purified ricin-a-chain species

Also Published As

Publication number Publication date
AU6519090A (en) 1991-04-18
DK0491865T3 (da) 1997-06-02
RU2113234C1 (ru) 1998-06-20
EP0491865A1 (en) 1992-07-01
CA2383393A1 (en) 1991-04-04
AU641439B2 (en) 1993-09-23
PL167444B1 (pl) 1995-09-30
PL286898A1 (en) 1991-06-03
PL168587B1 (pl) 1996-03-29
EP0491865A4 (en) 1993-05-05
DE69029396T2 (de) 1997-06-05
HU219327B (en) 2001-03-28
EP0491865B1 (en) 1996-12-11
NO920942D0 (no) 1992-03-11
IL95578A0 (en) 1991-06-30
PL167882B1 (pl) 1995-11-30
CA2066221C (en) 2002-07-23
FI921111A0 (fi) 1992-03-13
JP2001309795A (ja) 2001-11-06
FI105154B (fi) 2000-06-30
KR920703097A (ko) 1992-12-17
NZ235316A (en) 1992-11-25
YU176490A (sh) 1992-12-21
CA2066221A1 (en) 1991-03-16
ATE146081T1 (de) 1996-12-15
IE903349A1 (en) 1991-04-10
JPH05500455A (ja) 1993-02-04
KR0180559B1 (ko) 1999-03-20
GR900100692A (el) 1992-01-20
IL95578A (en) 1998-08-16
DE69029396D1 (de) 1997-01-23
PT95316A (pt) 1991-06-25
ZA907297B (en) 1993-06-01
JP3447713B2 (ja) 2003-09-16
HUT63770A (en) 1993-10-28
WO1991004049A1 (en) 1991-04-04
NO920942L (no) 1992-05-12
NO313908B1 (no) 2002-12-23
ES2097154T3 (es) 1997-04-01

Similar Documents

Publication Publication Date Title
GR1002294B (el) Συνδυασμενο εμβολιο για streptococcus ομαδας β.
DE69002385D1 (de) Isolierung und strukturbestimmung des zytostatischen linearen depsipeptids dolastatin 15.
PL323822A1 (en) Polysaccharidic fragments of streotococcus type ii and type iii from antigenic group b processing terminal structure of 2,5-anhydro-d-mannose and conjugated cavvine made on their basis
CA1272952C (en) GLYCOPROTEINIC CONJUGATES HAVING TRIVALENT IMMUNOGENIC ACTIVITY
OA09776A (en) "Improved vaccine compositions".
NO304552B1 (no) Kompleksforbindelser, konjugater, farmas°ytiske preparater inneholdende slike og forbindelser
FI964189A0 (fi) Immunogeeniset ryhmä A-streptokokkaaliset polysakkaridikoostumukset ja menetelmät
AU8172094A (en) Synthetic HTLV-III peptides, compositions and uses thereof
PT891371E (pt) Derivados 9-oxima-sililo da eritromicina a
DE69826520D1 (en) 6-o-alkylerythromycinoxim b
DE69231663D1 (de) Konjugate bestehend aus polysaccharid und protein
CA2076347A1 (en) Improved antibody-enzyme direct conjugates and method of making same
ES2137310T3 (es) Vacuna contra una infeccion por streptococcus suis.
AU5537096A (en) Isolated frpb nucleic acid molecule and vaccine
TW218847B (el)
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
HUP9801917A2 (hu) Immunogén készítmény, eljárás annak előállítására és vakcinaként történő alkalmazására
FR2412564A1 (fr) Nouvelles 2' -n-acyl- et alkyl-6' -n-alkyl- et 6', 6' -di-n-alkyl-fortimicines a et b, utiles notamment comme antibiotiques
EP0345559A3 (en) Hiv-2 variants

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees